AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
This study is investigating a new treatment called IMPEDE-FX RapidFill. It's for people who have an abdominal aortic aneurysm (AAA), which is when the main blood vessel in your tummy gets swollen and weakened. The study wants to find out if using IMPEDE-FX RapidFill alongside a standard repair, called endovascular aneurysm repair (EVAR), can help the swollen artery shrink. By making the artery smaller, the hope is to reduce the risk of it bursting. Participants would be those already suitable for the standard EVAR procedure. The goal is to check how safe and effective this combination treatment is in improving the outcome for patients with an AAA.
במבט חטוף
על מה המחקר הזה?
This research is looking into a new approach to treat a condition called an abdominal aortic aneurysm (AAA). An AAA happens when the main blood vessel in your body, called the aorta, which runs through your tummy, swells up like a balloon. This can be dangerous because a very large aneurysm might burst, leading to serious bleeding. The standard way to fix this is an operation called EVAR (Endovascular Aneurysm Repair). This involves putting a special tube, called a stent graft, inside the swollen part of the aorta to strengthen it. This study is testing if adding a new material called IMPEDE-FX RapidFill during the EVAR procedure can help even more. The main aim is to see if using IMPEDE-FX RapidFill helps the swollen area of your aorta shrink more effectively than just EVAR alone. The researchers believe that if the aneurysm sac shrinks, it could be a safer long-term outcome for people with this condition. They will be carefully checking both the safety of this new combination treatment and how well it works.
נקודות עיקריות
- This study is testing a new way to treat abdominal aortic aneurysms (AAA).
- It combines standard EVAR surgery with a new material called IMPEDE-FX RapidFill.
- The main goal is to see if the new treatment helps the swollen artery shrink more.
- Participation involves your planned EVAR and regular check-ups afterwards.
- It aims to find safer and more effective treatments for AAA patients.
מי עשוי להיות זכאי?
To join this study, you would need to be at least 18 years old and be a good candidate for the usual EVAR operation for an abdominal aortic aneurysm. Your aneurysm would need to be a certain size – at least 5.5cm for men and 5.0cm for women. Doctors would also check that the aneurysm isn't too solid with blood clots and has a big enough open space inside it.
There are also reasons why you might not be able to join. For example, if you can't give your clear permission to take part, or if you're already in another study that might affect the results of this one. Certain other medical conditions, like some problems with blood vessel access or specific types of aneurysms (like those that have burst or are infected), would also mean you couldn't participate. Also, if you need a type of EVAR device that isn't being tested in this study, you wouldn't be able to join.
האם מחקר זה יכול להתאים לך?
ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.
- האם אתה לפחות בן 18?
- Have you been told you need a standard EVAR operation for an AAA?
- Is your aneurysm a suitable size (your doctor will know this)?
- Do you have certain other serious health problems that might exclude you?
- Are you willing and able to attend follow-up appointments?
מה כרוך בהשתתפות?
The study aims to see how safe and effective the IMPEDE-FX RapidFill treatment is when added to your planned EVAR procedure. You would undergo the EVAR operation as planned, with the additional material inserted at the same time. After your procedure, you would have regular follow-up visits with the study team. These visits will involve checks to see how you are recovering and how the aneurysm is responding to the treatment. This will likely involve scans to measure your aneurysm and discussions about your general health. The exact number and timing of visits will be explained in detail, but they are crucial for monitoring your progress and collecting important information for the study.
סיכונים ותועלות פוטנציאליים
Locations (49)
- University of Alabama Birminghamמיקוד מאומתבירמינגהם, ארצות הברית
- Honor Healthמיקוד מאומתסקוטסדייל, ארצות הברית
- USC Keckמיקוד מאומתלוס אנג'לס, ארצות הברית
- San Diego VA Medical Centerמיקוד מאומתסן דייגו, ארצות הברית
- Delray Medical Centerמיקוד מאומתDelray Beach, United States
- Mt. Sinai Medical Centerמיקוד מאומתמיאמי ביץ', ארצות הברית
- Orlando Healthמיקוד מאומתאורלנדו, ארצות הברית
- אוניברסיטת דרום פלורידהמיקוד מאומתטמפה, ארצות הברית
- Emory University Hospitalמיקוד מאומתאטלנטה, ארצות הברית
- אוניברסיטת שיקגומיקוד מאומתשיקגו, ארצות הברית
- אוניברסיטת אינדיאנהמיקוד מאומתאינדיאנפוליס, ארצות הברית
- Maine Medicalמיקוד מאומתפורטלנד, ארצות הברית
שאלות נפוצות
What is an abdominal aortic aneurysm?
It's when the main blood vessel in your tummy (aorta) swells up. If it gets too big, it can be serious.
What is EVAR?
EVAR is a common operation where a special tube is put inside the swollen artery to strengthen it.
What is IMPEDE-FX RapidFill?
It's a new material being tested to see if it can help the swollen artery shrink more effectively when used with EVAR.
Will I get the new treatment?
If you are eligible and choose to participate, you would receive the IMPEDE-FX RapidFill as an addition to your standard EVAR procedure.
האם אני יכול לעזוב את המחקר אם אשנה את דעתי?
Yes, you can leave the study at any time, and it won't affect your medical care.
כיצד לגלות עוד
תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.
דיון
דיון קהילתי
מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.